Abstract:Antibodies are critical components of the human adaptive immune system, providing versatile scaffolds to display diverse antigen-binding surfaces. Nevertheless, most antibodies have similar architectures, with the variable immunoglobulin domains of the heavy and light chain each providing three hypervariable loops, which are varied to generate diversity. The recent identification of a novel class of antibody in humans from malaria endemic regions of Africa was therefore surprising as one hypervariable loop con… Show more
“…Mass spectrometry identified the target antigens for LAIR1 as belonging to members of the repetitive interspersed families of polypeptides (RIFIN) family -the largest family of P. falciparum antigens displayed on infected erythrocytes 9 . Furthermore, X-ray crystallography analyses 11 revealed that LAIR1 is well folded and is displayed on the tip of V region in an appropriate configuration for interaction with antigen (FIG. 1A).…”
Section: [H2] Non-ig V Region Insertionsmentioning
confidence: 99%
“…The antigens are presented as shapes in dark blue. Right panels: side and top views of the structural representations of antibody MGD21 with LAIR1 insertion and of the broadly neutralizing HIV-1 antibody 3BNC60 with indel (created using PDB file 5NST 11 , and 3RPI 117 , respectively). The structural models were visualized by UCSF Chimera software package 118 .…”
Section: Box 2 Conventional Mechanisms For Antibody Diversificationmentioning
Antibodies are an essential component of adaptive immunity. A typical antibody repertoire comprises an enormous diversity of antigen-binding specificities, which are generated by the genetic processes of recombination and mutation. Accumulating evidence suggests that the immune system can exploit additional strategies to diversify the repertoire of antigen specificities. These unconventional mechanisms exclusively target the antigen-binding sites of immunoglobulins and include the insertion of large amino acid sequences, post-translational modifications, conformational heterogeneity, and use of non-proteinaceous cofactor molecules. Here, we describe the different unconventional routes for diversification of antibody specificities. Furthermore, we highlight how the immune system has a much greater level of adaptability and plasticity than previously anticipated, which goes far beyond that encoded in the genome or generated by the acquisition of somatic mutations.
“…Mass spectrometry identified the target antigens for LAIR1 as belonging to members of the repetitive interspersed families of polypeptides (RIFIN) family -the largest family of P. falciparum antigens displayed on infected erythrocytes 9 . Furthermore, X-ray crystallography analyses 11 revealed that LAIR1 is well folded and is displayed on the tip of V region in an appropriate configuration for interaction with antigen (FIG. 1A).…”
Section: [H2] Non-ig V Region Insertionsmentioning
confidence: 99%
“…The antigens are presented as shapes in dark blue. Right panels: side and top views of the structural representations of antibody MGD21 with LAIR1 insertion and of the broadly neutralizing HIV-1 antibody 3BNC60 with indel (created using PDB file 5NST 11 , and 3RPI 117 , respectively). The structural models were visualized by UCSF Chimera software package 118 .…”
Section: Box 2 Conventional Mechanisms For Antibody Diversificationmentioning
Antibodies are an essential component of adaptive immunity. A typical antibody repertoire comprises an enormous diversity of antigen-binding specificities, which are generated by the genetic processes of recombination and mutation. Accumulating evidence suggests that the immune system can exploit additional strategies to diversify the repertoire of antigen specificities. These unconventional mechanisms exclusively target the antigen-binding sites of immunoglobulins and include the insertion of large amino acid sequences, post-translational modifications, conformational heterogeneity, and use of non-proteinaceous cofactor molecules. Here, we describe the different unconventional routes for diversification of antibody specificities. Furthermore, we highlight how the immune system has a much greater level of adaptability and plasticity than previously anticipated, which goes far beyond that encoded in the genome or generated by the acquisition of somatic mutations.
“…In the causative agent of the most deadly human malaria, Plasmodium falciparum, RIFINs form the largest erythrocyte surface protein family 1 . Some RIFINs can bind inhibitory immune receptors, acting as targets for unusual antibodies containing a LAIR1 ectodomain 2 - 4 , or as ligands for LILRB1 5 . RIFINs stimulate LILRB1 activation and signalling5, thereby potentially dampening human immune responses.…”
The Plasmodium species that cause malaria are obligate intracellular parasites, and disease symptoms occur as they replicate within human blood. Despite risking immune detection, the parasite delivers proteins that bind host receptors to infected erythrocyte surfaces. In the causative agent of the most deadly human malaria, Plasmodium falciparum, RIFINs form the largest erythrocyte surface protein family
1
. Some RIFINs can bind inhibitory immune receptors, acting as targets for unusual antibodies containing a LAIR1 ectodomain
2
-
4
, or as ligands for LILRB1
5
. RIFINs stimulate LILRB1 activation and signalling5, thereby potentially dampening human immune responses. To understand this process, we determined a structure of a RIFIN bound to LILRB1. We show that the RIFIN mimics the natural activating ligand of LILRB1, MHC class I, in its LILRB1-binding mode. A single RIFIN mutation disrupts the complex, blocks LILRB1 binding by all tested RIFINs and abolishes signalling in a reporter assay. In a supported lipid bilayer system, which mimics NK cell activation by antibody- dependent cell-mediated cytotoxicity, both RIFIN and MHC are recruited to the NK cell immunological synapse and reduce cell activation, as measured by perforin mobilisation. Therefore, LILRB1-binding RIFINs mimic the binding mode of the natural ligand of LILRB1 and suppress NK cell function.
“…However, for peptides whose "active" structure (i.e., target-bound state) assume lasso-like conformation, loop-insertion often allows functional fusion 23,30 . In fact, such "binding-domain insertion" has been found in several natural antibodies where target-binding is mediated by small (~30 residues) to large (~100 residues) domain inserted at the tip of CDR3 loop 31,32 .…”
Engineering of multifunctional recombinant proteins are a promising approach for devising next-generation proteinous drugs that engage specific receptors on cell(s), but it often requires drastic modifications of the parental protein scaffolds, e.g., additional domains at the N/C-terminus (or termini) or replacement of a domain to another. A discovery platform system, called RaPID (Random non-standard Peptides Integrated Discovery) system, has enabled for a rapid discovery of small de novo macrocyclic peptides that bind a target protein with high binding specificity and affinity. Taking the advantage of such exquisite properties of the RaPID-derived peptides, here we show that their pharmacophore sequences can be implanted to a surface-exposed loop or loops of recombinant proteins and maintain not only the parental peptide binding function(s) but also the host protein function. By applying this method, referred to as lasso-grafting, many different proteins including IgG and serum albumin could be endowed with binding capability toward various receptors, allowing us to quickly formulate bi-, tri-, and even tetra-specific binder molecules. Moreover, lasso-grafting of a receptor-targeting peptide to capsid proteins of adeno-associated virus (AAV) has generated engineered AAV vectors that can infect cells solely dependent on the targeted receptor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.